EP3551189
ALPRAZÓLAM TIL AÐ NOTA Í MEÐFERÐ VIÐ FLOGAVEIKI
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
8.12.2017EP published:
1.11.2023EP application number:
17878604.2
EP translation filed:
26.1.2024Grant published:
15.3.2024EPO information:
European Patent Register
Max expiry date:
7.12.2037Expiry date:
7.12.2026Next due date:
31.12.2026
Title in English:
ALPRAZOLAM FOR USE IN TREATING EPILEPSYLanguage of the patent:
English
Timeline
Today
8.12.2017EP application
1.11.2023EP Publication
26.1.2024Translation submitted
15.3.2024Registration published
7.12.2026Expires
Owner
Name:
Alexza Pharmaceuticals, Inc.Address:
6550 Dumbarton Circle, Suite A, Fremont, CA 94555, US
Inventor
Name:
CASSELLA, JamesAddress:
Essex, Connecticut 06426, US
Name:
GONG, LilyAddress:
San Jose, California 95120, US
Name:
KAMEMOTO, Edwin S.Address:
Redwood City, California 94065, US
Agent
Name:
Budde Schou A/SAddress:
Dronningens Tværgade 30, DK
Priority
Number:
201662432353 PDate:
9.12.2016Country:
US
Number:
201762485281 PDate:
13.4.2017Country:
US
Classification
Categories:
A61K 31/5517, A61K 31/573, A61K 9/00, A61P 25/08
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 4.1.2024
Expires: 7.12.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 5.11.2024
Expires: 7.12.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 11.12.2025
Expires: 7.12.2026
Payer: Árnason Faktor ehf.